Asthma affects three hundred million people worldwide. The effectiveness of house dust mite allergen control for asthma treatment is debatable. One aspect that has been little discussed in existing meta-analyses is the possible role of environmental strategies. Here, we reintroduce the previously defined strategies for mite allergen control and discuss their importance to the debate on clinical effectiveness. The strategy of concurrent bedroom interventions is related to the combined use of a priori defined interventions, while the strategy of exposure-based control relates to the treatment of relevant textiles after assessing exposure. The air purification strategy aims to purify the human breathing zone of airborne allergens. In Western European patient practice, the use of these strategies differs. A post hoc study of the dominant Cochrane review by Gøtzsche and Johansen (Cochrane Database of Systematic Reviews, 2008, Art. No: CD001187) appears to indicate that a majority of the underlying trials reported on the strategy of concurrent bedroom interventions, which were mainly executed in a minimal manner. Some trials have reported on the air purification strategy and may potentially alter the debate on effectiveness. No trial has reported on the strategy of exposure-based control. We therefore hypothesize that the absence of evidence for the effectiveness of mite allergen control for asthma treatment applies to the strategy of concurrent bedroom interventions. The evidence-based effectiveness of the exposure-based control strategy appears to be undetermined. The results of our post hoc reanalysis urge that future meta-analyses of mite allergen control should a priori define the environmental strategy under study. Future trials of mite allergen control are warranted to test the exposure-based strategy as well as the sparsely tested strategy of air purification.
| INTRODUCTION
Asthma affects hundreds of millions of people worldwide, and its prevalence is still rising. 1, 2 The role of house dust mite allergy in asthma is evident; however, it is not exclusive. 3 Therapies have been developed for the treatment of allergic asthma, including avoidance of mite allergen exposure, immunotherapy and pharmacological treatment. 4 However, the effectiveness of mite allergen control has become debatable, 5 and existing guidelines show a lack of consensus on mite allergen control. [6] [7] [8] Therefore, gaining knowledge of the clinical effectiveness of avoiding allergen exposure should still be considered a research priority compared to controlling other types of exposure. 9, 10 The debate on the effectiveness of mite allergen control for the treatment of asthma has not been characterized by progress. For instance, repeated comments have been made on the meta-analysis by Gøtzsche et al, 5, 11, 12 pointing to the benefits of multiple trigger therapy in a large trial. 13 However, these types of comments have previously been rejected by Gøtzsche et al, 14 who said: "none of the correspondents have provided data (at the same level of evidence) to the contrary. Nevertheless, investigators 15 continue to mention the benefits of trials excluded previously by Gøtzsche and Johansen 16 One novelty seems to be the introduction of a hypothesis by Tovey and Ferro that the debate on effectiveness calls for personalized avoidance by a better understanding of the nature of allergen exposure. 17 A little-discussed aspect of the question of clinical effectiveness is the role of mite allergen control strategies. Strategies have been defined to avoid house dust mite allergen exposure (see the section "Strategies for mite allergen control"), including total avoidance, 18 exposure-based control, 19 concurrent bedroom interventions, 20 purification of the breathing air, 21 and a sojourn in a mite-free (alpine) environment. 22 Environmentally, the reduction in exposure by different strategies is not necessarily equivalent. It remains unclear whether the absence of evidence of the clinical effectiveness of mite allergen control relates to any particular strategy. In this review, we reintroduce previously defined strategies for mite allergen control and discuss their importance to the debate on clinical effectiveness, including future investigations.
| STRATEGIES FOR MITE ALLERGEN CONTROL

| Initial strategies
Among mono-and multi-trigger approaches, 23 strategies can be considered to control exposure to house dust mites and their allergens.
Prior strategies have related to the removal of the patient to a mitefree environment. A sojourn in a Swiss alpine mite-free environment has been used more than a hundred years and shown to benefit asthmatic patients temporarily. 22 Platts-Mills et al 24 removed patients for 2 months or more to a dust-free hospital environment, resulting in significantly reduced bronchial hyperreactivity. These prior strategies were continued by the strategy of total avoidance of the home environment of the asthmatic patients. This strategy of total avoidance has defined a combination of measures aiming for an indoor environment completely free of living and dead house dust mites as well as their faecal products. 18, 25 The measures developed have included mainly acaricidal products and mite-impermeable covers. However, it became clear that the strategy of total avoidance is rarely achievable by patients in the long term. 26 
| Textile-based strategies
Meanwhile, strategies were defined to gain the benefits of rigorous and intensive total avoidance using a more efficient approach. Colloff 20 defined a set of a priori defined barriers, called integrated avoidance. We redefine this approach as the strategy of concurrent bedroom interventions: a combined approach aimed at controlling house dust mite exposure by primarily treating the bedroom environment with a priori defined barriers. The original strategy comprises a total of seven barriers. In a more recent publication, Colloff updated the strategy to nine barriers. 27 The five primary barriers consist of (a) Around the same period, van Bronswijk 19 introduced the strategy of selective avoidance. We redefine this strategy as exposure-based control: a combined approach based on the assessment of the actual exposure in the home environment, followed by the extermination of mites and removal of all relevant sources of allergenic dust. This strategy assumes the existence of a hygienic threshold for allergen exposure above which symptoms will develop (2 μg/g dust). 25 A simple colorimetric test was introduced in patient practice that related the actual exposure in the home environment to the hygienic threshold. 28 In the worst case, the exposure-based strategy results in total avoidance of the home environment. 35 or an air filtration unit in the living room. 
| Mixed strategies
Finally, we introduce mixed strategies, referring to a combination of strategies that differ in aim or therapy, such as combining the effectiveness of steroids, immunotherapy, and impermeable covers from different trials in one meta-analysis without subgrouping. We consider the mixed strategies somewhat unwieldy. Even if they are clinically effective, the results of mixed strategies are less usable or less efficient for patient practice, particularly when a strategy is not completely executed. For instance, patient practice does not combine a partial impermeable cover with a partial HEPA filter. An exception is the case when all data from a study result from concurrent and completely executed strategies. Therefore, insight into the effectiveness of a single strategy is relevant for evidence-based clinical decision-making.
| EVIDENCE SUPPORTING THE STRATEGIES
| List of meta-analyses
In the section above, we reintroduced the environmental strategies for mite allergen control. After the introduction of textile-based strategies in the early 1990s, the first meta-analysis was performed to assess the effectiveness of mite allergen control at the highest level of evidence. 5 This meta-analysis was later continued in a Cochrane review. 37 In this meta-analysis, Gøtzsche and Johansen included trials on mite-impermeable covers as well as air purification; thus, they investigated a mixture of strategies. The next meta-analysis studied the effectiveness of purifying the air using air filtration for the treatment of allergic asthma. 38 that covered all bedding elements (mattress, duvet, and pillow), fitting it to the definition of the strategy of concurrent bedroom interventions. 27 Huiyan et al 44 investigated six trials on mite-impermeable covers combined with one trial on humidity control. Three of the trials investigated by Huiyan et al [38] [39] [40] [41] [42] [43] [44] were also included in the analysis by Gøtzsche and Johansen. 37 To some extent, many metaanalyses can be considered to represent subsets of the large metaanalysis by Gøtzsche and Johansen. to −0.13 by two trials). Van Boven 43 observed that the more bedroom interventions were combined, the higher the reduction in the mite load from the mattress when the load was high at baseline (P = 0.02; nine trials). Among the listed meta-analyses, the meta-analysis by Gøtzsche on a mix of strategies without subgrouping, the role of the specific strategies remains unclear.
| THE POSSIBLE ROLES OF STRATEGIES IN E FFECTIVENESS: AN EXAMPLE
| Methods
The debate on effectiveness is dominated by the large and rigorous meta-analysis by Gøtzsche and Johansen. 37 This meta-analysis on a mix of strategies did not subgroup for possible differences between mite allergen control strategies. We post hoc subgrouped the results by Gøtzsche and Johansen 37 into categories based on the environmental strategy used for mite allergen control. The extractions as published by Gøtzsche and Johansen 37 were the basis of this reanalysis.
Outcomes were limited to the number of patients improved, the medication usage, the asthma symptom score, the forced expiratory volume in one-second (FEV 1 ), and the histamine or methacholine concentration that caused a 20% reduction in FEV 1 (PC 20 ).
The assessment of the type of strategy as studied in the underlying trials yielded three judgements:
• Assessing the strategy used to control mite allergen exposure.
The strategy was defined as "concurrent bedroom interventions"
for any a priori defined intervention aimed at reducing the mite allergen load while not assessing the relevant sites of exposure in the home environment.
• If the intervention was judged to follow the strategy of concurrent bedroom interventions, we assessed the number of barriers used.
• If the strategy of concurrent bedroom interventions was not followed consequently, the number of barriers was set at one. (Table 2) . Heterogeneity ranged from I 2 = 54%-91%. For FEV 1 , the SMD ranged from +0.07 to +0.17, with P-values ranging from 0.08 to 0.81 and negligible heterogeneity (I 2 = 0%-28%; Table 3 ). Three subgroups reported on PC 20 outcome, with the SMD ranging from −0.12 to +0.05 (P = 0.45-0.80; Table 4 ). The subgroups showed no heterogeneity (I 2 = 0%). For medication usage, two subgroups reported an SMD = −0.04 to −0.17 (P = 0.46-0.49; I 2 = 0%; Table 5 ). The risk ratio for the number improved in the subgroups of concurrent bedroom interventions was 0.85-1.07 (P = 0.77-0.87), with an absence of heterogeneity (Table 6 ).
In the subgroup of air purification, we found a non-significant risk ratio of 0.67 (P = 0.61), with an absence of heterogeneity.
| Discussion of the subgrouping analysis
Overall, post hoc subgrouping shows that the environmental intervention studied in the meta-analysis by Gøtzsche and Johansen Only the strategy of removing patients from an environment with high mite allergen exposure is clearly accepted as effective. 14, 24 Most of the recent meta-analyses of textile-based mite allergen control for the treatment of asthma do not relate their findings to a strategy. 
| On textile-based strategies
A post hoc reanalysis of the dominant meta-analysis by Gøtzsche and Johansen 37 suggests that a majority of the trials examined had reported on the use of concurrent bedroom interventions executed in a minimal manner. The exposure-based strategy was not tested in the included trials. This result suggests that it is unknown whether the conclusion by Gøtzsche and Johansen 37 is valid for the exposure-based strategy. In our opinion, the choice of the strategy of concurrent bedroom interventions reflects the principals of traditional clinical trial design. 84 In a clinical experiment, the aim is to test for a possible difference between treatment and no treatment. A secondary aim in a clinical experiment is to minimize the variance in outcomes to discriminate a treatment effect in as unbiased a manner as possible. 85 Among the many issues playing a role in minimizing variance in a trial, we consider the choice of a predefined simple and homogeneous treatment to be one, for instance, such as the choice of single bedding covers. However, the opposite of minimizing the variance is the considerable heterogeneity present in personal exposure. Studies on personal airborne exposure [86] [87] [88] show that relevant average exposure is not necessarily related to the sleeping site. Environmentally, emission sources, emission magnitudes, emission frequencies, and the presence of patients at emission sites may all vary.
The considerable variance in exposure in patient practice calls for an exposure-based strategy. Nonetheless, we do not know of any study comparing the (clinical) effectiveness of the frequently tested strategy of concurrent bedroom interventions with the exposure-based strategy. This research question is relevant, as highly skilled health practitioners from France and The Netherlands advise their patients by use of the exposure-based strategy.
89-90
| Recent studies
Additionally, recent studies have not related their findings to a specific strategy. Leas et al 91 systematically reviewed the effectiveness of T A B L E 2 Standardized mean differences in asthma symptom scores related to environmental strategy in the meta-analysis by Gøtzsche 
| Developing the debate?
What does our reintroduction of strategies add to the debate on allergen control? As stated above, the debate on the effectiveness of mite allergen control for asthma treatment has not been characterized by progress. Our reintroduction of environmental strategies of mite allergen control continues the call for re-thinking avoidance. 17 This call introduces the idea of improved measurement of personal exposure, 88, 94 reflecting the strategy of exposure-based control.
Exposure-based control was not the subject of study in any of the tri- 
| Other domains
Investigations on other allergic disorders caused by mites seem to
show an identical tendency in strategies. Sheikh et al 95 
| CONCLUSION
In summary, the clinical effectiveness of mite allergen control for the treatment of asthma is debatable. 37 It remains unclear whether the absence of evidence relates to a specific type of environmental strategy for mite allergen control, several of which were introduced in the early 1990s. A post hoc reanalysis suggests that the dominant conclusions by Gøtzsche and Johansen 37 relate to the strategy of concurrent bedroom interventions, which were mainly executed in a minimal manner. An evidence-based effectiveness assessment of the exposure-based control strategy, which is used in Western European patient practice, is still needed. Our post hoc findings indicate that future meta-analyses of mite allergen control should a priori define control are warranted to test the exposure-based strategy as well as the sparsely tested strategy of air purification.
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